Demand for digital health technology is on the rise. According to Digital Authority Partners, “Telemedicine, artificial intelligence (AI)-enabled medical devices, and blockchain electronic health records are just a few concrete examples of digital transformation in healthcare which are completely reshaping how we interact with health professionals, how our data is shared among providers and how decisions are made about our treatment plans and health outcomes.” That’s where a company, like AI/ML Innovations (CSE:AIML)(OTC:AIMLF) and its Health Gauge subsidiary, a leading digital health solutions provider, may be able to help.
Health Gauge is a leading digital health solutions provider – in a potential $245 billion global digital health monitoring market -- poised to transform the traditional healthcare industry by providing AI innovations and services which improve health outcomes while reducing costs and stresses on the overburdened healthcare infrastructure. In fact, digital health solutions may be able save the healthcare industry billions of dollars – and give care givers, patients, and health professionals easy access to necessary health data far quicker. Along with AI/ML Innovations, other top companies to watch include Revive Therapeutics Ltd. (CSE:RVV)(OTC:RVVTF), Mydecine Innovations Group Inc. (NEO:MYCO)(OTC:MYCOF), Empower Clinics Inc. (CSE:CBDT)(OTC:EPWCF), and CloudMD Software & Services Inc. (TSXV:DOC)(OTC:DOCRF).
AI/ML’s Health Chosen to Participate in Leading Accelerator Programs
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) was selected to participate in several of the foremost US-based Accelerator Programs, designed to help advance promising digital health technology companies towards profitability.
“The fact that Health Gauge was chosen, amongst a select few, to participate in these world-class programs is a real testament and further validation of Health Gauge’s transformative technology and business model” said Tim Daniels, Executive Chairman of AI/ML Innovations Inc. “Health Gauge continues to benefit from the knowledge and relationships acquired through its participation in these programs.”
Health Gauge successfully participated in and benefited from the following programs:
MATTER.health (Chicago, IL): Health Gauge was one of only five Canadian companies selected to participate in Chicago’s world-recognized MATTER.health program in 2019. Health Gauge remains an alumni organization and maintains connections there, leveraging these relationships for the advancement of Health Gauge’s market penetration strategy.
MATTER.health is world-recognized for the quality of its program that creates positive dynamics for digital health companies and leaders to interact on addressing next generation solutions. With MATTER’s non-profit and no-equity model as the foundation, its community is a neutral platform where healthcare entrepreneurs can come together with industry leaders, scientists and clinicians from across the globe to collaborate on developing next-generation healthcare and life sciences technologies.
CELS-SFO Canadian Entrepreneurs in Life Sciences (Silicon Valley, CA): Health Gauge was selected among a group of only ten companies to participate in its program designed to support the advancement of innovative Canadian Life Science businesses in the San Francisco Bay Area and Silicon Valley through the power of community and connections and the access to capital in Silicon Valley.
CELS is the leading Canadian program that assists Canadian innovation-oriented companies in launching in the United States, as well as providing experienced and influential connections in Silicon Valley and across the United States.
Newchip (Austin, TX): Health Gauge was approached by Newchip in 2020 to participate in their health tech-oriented business development program, which attracts and works with companies from around the world. Health Gauge has been applying the diverse set of online services afforded by Newchip to build out contacts in the community across the United States.
The Newchip Accelerator Program was developed to operate like an Executive MBA program. Their network includes a team of expert mentors and a global community of founders, angel investors, and venture capitalists.
Other related developments from around the markets include:
Revive Therapeutics Ltd., a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce it has entered into an agreement with the University of Health Sciences Antigua to collaborate on utilizing Revive’s novel psychedelic-assisted therapies and pioneering the clinical research and development of psychedelics in Antigua and Barbuda.
Mydecine Innovations Group has selected substance use disorder and smoking cessation as the initial target indications for its proprietary psychedelic molecule MYCO-004. MYCO-004 is a patch-delivered tryptamine compound and its properties include short duration (less than two hours), transdermal, precision dosing, and long-term compound stability. Mydecine said it picked substance use disorder and smoking cessation for MYCO-004 as it addresses the underserved and drastic need for treatment. The company noted that there are 19.7 million American adults suffering from substance abuse disorder. Of those, 8.5 million suffer from both substance abuse disorder and mental health disorders.
Empower Clinics Inc. announced the signing of six Letters of Intent (LOI’s) to open medical healthcare centers with REXALL/PHARMA PLUS PHARMACIES LTD the second largest pharmacy group in Canada. It is proposed that Empower will act as a subtenant for these initial six locations to build and operate health care centers as a key driver of Empower’s national clinic expansion strategy. Services include full primary care led by medical doctors plus paramedical services with practitioners providing services including chiropractic care, physiotherapy and more. Beneficiaries of these services include the pharmacies large existing customer base in addition to patients in the wider communities each location will serve.
CloudMD Software & Services Inc., a healthcare technology company revolutionizing the delivery of care, announced its financial results for the first quarter ended March 31, 2021. All financial information is presented in Canadian dollars unless otherwise indicated. Dr. Essam Hamza, CEO of CloudMD commented, “We are excited to share our record Q1 2021 financial results that continue to improve quarter over quarter. Q1 was a transformative period for CloudMD, as we closed 5 acquisitions, adding $13 million in annualized revenue and establishing the foundation for our Enterprise Health Solutions division. I am very proud of the strategic roadmap we have built and the team’s ability to execute on our growth strategy. We identified key acquisition targets that were synergistic to our overall vision and we remain focused on building a complete healthcare ecosystem, providing connected, holistic care. We continue to integrate all of our capabilities into one comprehensive platform, which is the foundation for scale and expansion.”
Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. AI/ML Innovations Inc. has paid three thousand five hundred dollars for advertising and marketing services to be distributed by Winning Media. Winning Media is only compensated for its services in the form of cash-based compensation. Winning Media owns ZERO shares of AI/ML Innovations Inc. Please click here for full disclaimer.
Contact Information:
2818047972
[email protected]
